Skip to content

Methylprednisolone

Medrol (methylprednisolone) is a small molecule pharmaceutical. Methylprednisolone was first approved as Medrol on 1982-01-01. It is used to treat adrenal insufficiency, ankylosing spondylitis, asthma, atopic dermatitis, and berylliosis amongst others in the USA. The pharmaceutical is active against glucocorticoid receptor. In addition, it is known to target short transient receptor potential channel 5.
Trade Name Medrol
Common Name Methylprednisolone
Indication adrenal insufficiency, ankylosing spondylitis, asthma, atopic dermatitis, berylliosis, brain neoplasms, dermatitis herpetiformis, erythema multiforme, graft vs host disease, hematologic diseases, hypercalcemia, inflammation, leukemia, multiple sclerosis, mycosis fungoides, nephrotic syndrome, neurologic manifestations, pemphigus, pulmonary tuberculosis, respiratory distress syndrome, rheumatic diseases, sarcoidosis, serum sickness, synovitis, systemic lupus erythematosus, thyroiditis, ulcerative colitis, uveitis
Drug Class Prednisone and prednisolone derivatives
Methylprednisolone
Get full access now